{
    "organizations": [],
    "uuid": "f170bcb599d63050d915d797f7ad3452ac6e2744",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-grants-paxvax-fast-track-desig/brief-fda-grants-paxvax-fast-track-designation-for-its-chikungunya-vaccine-idUSASC09ZWZ",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Grants PaxVax Fast Track Designation For Its Chikungunya Vaccine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 4 (Reuters) - PaxVax:\n* FDA GRANTS PAXVAX FAST TRACK DESIGNATION FOR ITS CHIKUNGUNYA VACCINE\n* PAXVAX SAYS HAS RECEIVED FAST TRACK DESIGNATION FROM U.S. FDA FOR ITS VACCINE FOR PREVENTION OF DISEASE CAUSED BY CHIKUNGUNYA VIRUS\n* PAXVAX SAYS EXPECTS RESULTS FROM ITS PHASE 2B DOSE-FINDING TRIAL OF CHIKUNGUNYA VLP VACCINE IN EARLY 2019 Source text for Eikon:\n ",
    "published": "2018-05-04T20:27:00.000+03:00",
    "crawled": "2018-05-05T12:01:07.027+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "paxvax",
        "fda",
        "grant",
        "paxvax",
        "fast",
        "track",
        "designation",
        "chikungunya",
        "vaccine",
        "paxvax",
        "say",
        "received",
        "fast",
        "track",
        "designation",
        "fda",
        "vaccine",
        "prevention",
        "disease",
        "caused",
        "chikungunya",
        "virus",
        "paxvax",
        "say",
        "expects",
        "result",
        "phase",
        "2b",
        "trial",
        "chikungunya",
        "vlp",
        "vaccine",
        "early",
        "source",
        "text",
        "eikon"
    ]
}